---
figid: PMC7407016__JO2020-5418365.001
figlink: pmc/articles/PMC7407016/figure/fig1/
number: Figure 1
caption: 'Regulatory circuits driven by liganded ER-alpha for DNA stabilization (A),
  cell proliferation (B), and fuel supply (C). Circuit A: Estrogen- (E2) activated
  estrogen receptor alpha (ERα) upregulates estrogen signaling via a regulatory circuit
  together with genome stabilizer protein (BRCA1) and aromatase enzyme (A450). Activated
  ER-alpha induces messenger RNA (mRNA) expressions on ESR1, BRCA1, and Cyp19A aromatase
  promoter regions upregulating the synthesis of ER-alpha, BRCA1, and aromatase enzyme.
  Aromatase enzyme produces estrogen hormones for further ER activation. In addition,
  activated ER-alpha may induce activating mutations on ESR1, BRCA1, and Cyp19A genes
  through the expression and activation of appropriate long noncoding RNAs (lncRNAs).
  In addition, ER-alpha and BRCA proteins are capable of direct binding as transcriptional
  factors regulating each other''s activity. Circuit B: Estrogen activated ERα is
  the crucial regulator of increased and decreased cell proliferation in strong interplay
  with membrane-associated tyrosine kinase growth factor receptors, EGFRs and IGF-1Rs.
  ERs regulate the expression and activation of growth factors (GFs) and their receptors.
  Transduction of growth factor signaling (GFS) induces kinase cascades via PI3-K/AKT/mTOR
  and RAS/RAF/MEK/MAPK pathways, which are transmitted into the nucleus inducing expressions
  of specific genes through an unliganded activation of ERs. Circuit C: Estrogen activated
  ERα is the regulator of all steps of cellular glucose uptake and the maintenance
  of glucose homeostasis. Estrogen-regulated genes stimulate both insulin synthesis
  and insulin receptor (IR) expression. Activated ERα stimulates the expression and
  activation of GLUT4 facilitating cellular glucose uptake. In addition, estrogen-activated
  ERα at the plasma membrane stimulates the kinase cascade of the PI3-K/AKT/mTOR pathway
  via IRS-1 activation. These signals induce specific gene expressions in the nucleus
  conferred by unliganded ERα activation. CA: coactivator, AF2: ligand binding domain,
  and AF1: nonligand binding domain.'
pmcid: PMC7407016
papertitle: Compensatory Estrogen Signal Is Capable of DNA Repair in Antiestrogen-Responsive
  Cancer Cells via Activating Mutations.
reftext: Zsuzsanna Suba. J Oncol. 2020;2020:5418365.
pmc_ranked_result_index: '33357'
pathway_score: 0.8939219
filename: JO2020-5418365.001.jpg
figtitle: Regulatory circuits driven by liganded ER-alpha for DNA stabilization (A),
  cell proliferation (B), and fuel supply (C)
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7407016__JO2020-5418365.001.html
  '@type': Dataset
  description: 'Regulatory circuits driven by liganded ER-alpha for DNA stabilization
    (A), cell proliferation (B), and fuel supply (C). Circuit A: Estrogen- (E2) activated
    estrogen receptor alpha (ERα) upregulates estrogen signaling via a regulatory
    circuit together with genome stabilizer protein (BRCA1) and aromatase enzyme (A450).
    Activated ER-alpha induces messenger RNA (mRNA) expressions on ESR1, BRCA1, and
    Cyp19A aromatase promoter regions upregulating the synthesis of ER-alpha, BRCA1,
    and aromatase enzyme. Aromatase enzyme produces estrogen hormones for further
    ER activation. In addition, activated ER-alpha may induce activating mutations
    on ESR1, BRCA1, and Cyp19A genes through the expression and activation of appropriate
    long noncoding RNAs (lncRNAs). In addition, ER-alpha and BRCA proteins are capable
    of direct binding as transcriptional factors regulating each other''s activity.
    Circuit B: Estrogen activated ERα is the crucial regulator of increased and decreased
    cell proliferation in strong interplay with membrane-associated tyrosine kinase
    growth factor receptors, EGFRs and IGF-1Rs. ERs regulate the expression and activation
    of growth factors (GFs) and their receptors. Transduction of growth factor signaling
    (GFS) induces kinase cascades via PI3-K/AKT/mTOR and RAS/RAF/MEK/MAPK pathways,
    which are transmitted into the nucleus inducing expressions of specific genes
    through an unliganded activation of ERs. Circuit C: Estrogen activated ERα is
    the regulator of all steps of cellular glucose uptake and the maintenance of glucose
    homeostasis. Estrogen-regulated genes stimulate both insulin synthesis and insulin
    receptor (IR) expression. Activated ERα stimulates the expression and activation
    of GLUT4 facilitating cellular glucose uptake. In addition, estrogen-activated
    ERα at the plasma membrane stimulates the kinase cascade of the PI3-K/AKT/mTOR
    pathway via IRS-1 activation. These signals induce specific gene expressions in
    the nucleus conferred by unliganded ERα activation. CA: coactivator, AF2: ligand
    binding domain, and AF1: nonligand binding domain.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IGF1R
  - EGFR
  - HRAS
  - KRAS
  - NRAS
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - ARAF
  - BRAF
  - RAF1
  - EFNA5
  - MAPK14
  - MAPK3
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK1
  - MAPK9
  - MAPK10
  - MAP2K1
  - MAP2K2
  - AKT2
  - AKT3
  - AKT1
  - BRCA1
  - MTOR
  - IRS1
  - SLC2A4
genes:
- word: IGF-1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: AF1
  symbol: AF1
  source: hgnc_alias_symbol
  hgnc_symbol: EFNA5
  entrez: '1946'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: МЕК
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: BRCA1
  symbol: BRCA1
  source: hgnc_symbol
  hgnc_symbol: BRCA1
  entrez: '672'
- word: mTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: mTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: ΑΚΤ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: ΑΚΤ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: ΑΚΤ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: IRS-1
  symbol: IRS1
  source: hgnc_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: GLUT4
  symbol: GLUT4
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A4
  entrez: '6517'
chemicals: []
diseases: []
---
